Klarity connects you with licensed healthcare providers who can evaluate your COPD symptoms and prescribe umeclidinium online within 24 hours, offering convenient, private, and HIPAA-compliant telehealth services.
Umeclidinium is a long-acting muscarinic antagonist (LAMA) designed to relax airway muscles, helping relieve COPD symptoms like wheezing, shortness of breath, and coughing. It is administered via a once-daily inhaler, such as Incruse Ellipta.
This medication is suitable for long-term use under medical supervision. It is effective in reducing daily COPD symptoms and improving lung function when used consistently.
Getting a prescription through Klarity is simple:
Most appointments are available within 24 hours, and services are HIPAA compliant, ensuring your privacy and security.
The average cash price for umeclidinium in the U.S. ranges from $250 to $400 per month, depending on brand or generic options and pharmacy discounts. You can reduce costs by using pharmacy discount programs like GoodRx or manufacturer savings cards.
Many insurance plans are accepted on Klarity; verify coverage during your appointment scheduling. Always confirm final prices with your pharmacy, especially if using insurance, as copays may vary.
Umeclidinium offers once-daily dosing, making it more convenient than some other bronchodilators like tiotropium or aclidinium, which may require multiple doses daily. It can be used alone or combined with other medications like vilanterol for enhanced effectiveness.
Compared to dual therapies like umeclidinium/vilanterol (Anoro Ellipta), monotherapy may be suitable for less severe COPD, but your provider will determine the best option based on your condition.
Klarity provides quick access to licensed, board-certified healthcare providers who specialize in respiratory conditions. Our telehealth platform allows you to:
Our network includes experienced clinicians with expertise in pulmonary medicine, ensuring you get safe and effective treatment for COPD.
Medical Disclaimer: The information provided is for educational purposes only and does not guarantee prescription or treatment. Always consult a healthcare professional for medical advice.
Yes, licensed providers on Klarity can evaluate and prescribe umeclidinium online for eligible adults in the U.S.
Umeclidinium is the active ingredient in Incruse Ellipta, an FDA-approved inhaler used daily for COPD maintenance.
Umeclidinium begins to improve lung function within hours, with full benefits after consistent daily use over several days.
Yes, umeclidinium is used for long-term management and can be combined with rescue inhalers for symptom relief; consult your provider first.
Yes, FDA-approved for long-term COPD management when prescribed and used as directed by your healthcare provider.
Book an appointment with a licensed Klarity provider at helloklarity.com. Receive a personalized evaluation, prescription if appropriate, and support to manage your COPD effectively from the comfort of your home.